Niki BioSolutions, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NIKI | TRAW | PCSA | APVO | MTNB | MREO | |
|---|---|---|---|---|---|---|
| Market cap | 5.27M | 4.13M | 5.41M | 2.90M | 1.17M | 48.40M |
| P/E (TTM) | — | — | — | 0.0 | — | — |
| Forward P/E | — | -0.1 | -0.5 | -0.1 | -0.4 | -13.1 |
| Price/book | 0.1 | 2.4 | -17.0 | 0.3 | 0.3 | 1.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −87.62% | −86.70% | −75.51% | −94.82% | −93.50% | −82.78% |
| Today | −3.98% | −11.06% | −0.26% | +0.74% | +4.39% | +4.16% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All NIKI news ›Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine
NYSDOH CLEP approval extends validated APOE genotyping beyond blood, buccal swab, saliva, and tissue for clinical and research useNEW HAVEN, CT an... Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using…
Niki Biosolutions, Inc. Announces Appointment of Thomas Freeburg as Chief Financial Officer, Effective September 1, 2026
Niki BioSolutions, Inc. on October 9, 2026, appointed Thomas Freeburg as the Chief Financial Officer, to serve at the discretion of the Board, for a period of two years, commencing as of September 1,... on October 9, 2026, appointed Thomas…
Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference
NEW HAVEN, CT and PRINCETON, NJ, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc. (NASDAQ: NIKI), a life sciences company focused on ... Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference NEW…
Niki BioSolutions’ Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation’s “Rett Research Tool Belt” Series
A 44-marker blood panel was evaluated in samples from over 200 people, with and without Rett syndrome. Stock Titan - Niki BioSolutions’ Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation’s “Rett Research…
Niki BioSolutions appoints Thomas Freeburg as CFO
Funding conditions govern deferred pay and a possible salary increase, while the agreement also sets bonus, option, and termination terms. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Pursuant to Section 13 OR…
Niki BioSolutions’ DiamiR Selected for IRSF Rett Research Tool Belt to Highlight Blood-Based microRNA Biomarker Panel
Niki BioSolutions announces participation in Rett Research Tool Belt, highlighting a microRNA biomarker panel for monitoring Rett syndrome. Niki BioSolutions focuses on unmet medical needs and genomic and biomarker testing solutions for…
Niki BioSolutions Accelerates Its Alzheimer?s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics
DiamiR Biosciences engaged Fios Genomics, a specialist provider of bioinformatics and biostatistics services, to perform bioinformatics and statistical analysis in support of the Company?s Alzheimer?s... Biotechnology & Medical Research…
Niki Biosolutions, Inc. Announces Management Changes, Effective August 1, 2026
Niki BioSolutions, Inc. appointed Mr. Chung Yuen Ian Huen as Chairman of the Board of Directors of the Company, effective August 1, 2026. Mr. Huen was also appointed as Chairman of the Board of... Chung Yuen Ian Huen as Chairman of the…
Niki BioSolutions Partners with Global Alzheimer’s Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002
Niki says the collaboration expands its visibility with biopharma and diagnostics companies that rely on Bio-Hermes data. Earlier agreement covered APOE genotyping services for PMR research programs using the approved testing platform.…
Niki BioSolutions, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Niki BioSolutions, Inc. with the company of your choice via a Relative Strength chart. Real-time NIKI price, Nasdaq stock exchange Relative Strength Chart Niki BioSolutions, Inc. Biotechnology & Medical Research All financial news…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com6
- stocktitan.net5
- markets.businessinsider.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.